Related to Gamma Partners with Health Diagnostic Lab to Develop Risk Assay for Heart Attack and Stroke

• Techne Buys Bionostics for $104M
  
• Lophius Wins $469K to Develop MS Diagnostic
  
• Thermo Fisher Scientific Launches Biomarker Test for Heart Attack in Europe
  
• Biosearch Grants Micronics Rights to Its Nucleic Acid Assay Chemistries
  
• Celera Gets CE Mark for KIF6 Genetic Test for Coronary Heart Disease Risk
  
• Predictive Biosciences Secures $25M to Push On with Bladder Cancer Test
  
• FDA Gives Abbott a Thumbs-Up for Automated HBV Monitoring Test
  
• Researchers Report Success with Assay Based on Asuragen’s RUO Reagents for NPM1 Mutations in AML Patients
  
• DSP Nabs U.S. and Canadian Marketing Option to SanBio’s Phase I Cell Therapy
  
• AutoGenomics Granted FDA Approval for Infiniti CYP2C19 Assay
  
• BioMérieux Makes €9M Investment in Biocartis as Part of MDx Assay Deal
  
• Biocartis Signs Assay Deal for Its MDx Platform with Janssen Pharmaceutica
  
• Qiagen Takes Minority Slice of Alacris to Access Biomarker Technology
  
• Seegene’s SeePlex Multiplex MDx Assays Available for Caliper’s LabChip Dx Platform
  
• Morphotek and Biocare Partner to Develop mAb-Based Assay for Cancer Antigen
  
• BD Diagnostics Taps Diagenode to Develop Seven IVDs for BD Max System
  
• Health Diagnostic Laboratory Purchases Harris Scientific for Omega-3 Fatty Acid Testing
  
• DxTerity Acquires Cancer Gene Expression Assay IP from SourceMDx
  
• FDA Grants 510(k) Clearance for Mitsubishi’s Pathfast Cardiac Troponin I Assay
  
• Metamark and Definiens Partner to Develop Tissue-Based Cancer Diagnostics